ARL BIO PHARMA, INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for ARL BIO PHARMA, INC

Sort by

Viewing results 1‒25 of 37

LexMergers & Acquisitions
This Japanese buyer is paying up to find a US home for growth Premium content
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
January 18, 2024
Japanese business & finance
Japan’s Astellas to buy US biotech group Iveric Bio for $5.9bn
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
May 1, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Pfizer Inc
Pfizer to buy oncology-focused biotech Seagen for $43bn
...Pfizer’s chief executive Albert Bourla said the pharma group was “deploying its financial resources to advance the battle against cancer”....
March 13, 2023
Pfizer Inc
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
April 5, 2022
News in-depthCovid-19 vaccines
Why the three biggest vaccine makers failed on Covid-19
...In parallel, in March it announced that it would work with Translate Bio on an mRNA Covid-19 vaccine....
February 16, 2021
Due Diligence
The winners and losers from a pharma mega-deal Premium content
...This is, of course, not the first time we’ve discussed AstraZeneca, the Cambridge-based pharma group, in DD this year....
December 15, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthThe Big Read
Covid vaccines offer Big Pharma a chance of rehabilitation
...Jeremy Levin, chair of the US biotech trade association BIO, says Mr Trump was “seemingly vindictive”, trying to harm the entire sector....
November 27, 2020
Covid-19 vaccines
Merck abandons bid to develop Covid-19 vaccine
...The second drug is an antiviral in phase 2/3 clinical trials, being developed with Ridgeback Bio. It could be the first oral therapeutic, which patients would be able to take outside the hospital....
January 25, 2021
FT SeriesCompanies prospering in the pandemic
Pharma industry seizes on pandemic as a shot at redemption
...been a political piñata in January to a recognition, at least in the minds of many policymakers, that this is an industry that we must support,” said Jeremy Levin, chairman of the industry association BIO...
July 6, 2020
Pharmaceuticals sector
Pharma industry faces hypocrisy charge over patents
...However, some companies contacted by the FT declined to join Bio’s full-throated defence of Allergan’s arrangement with the tribe, which has brought unwanted attention to the pharma industry as it tries...
November 1, 2017
US & Canadian companies
US drugmaker Gilead agrees $12bn deal to buy rival Kite Pharma
...Shares in other Car-T manufacturers shot up in pre-market trading in New York, with Juno adding nearly 14 per cent and Bluebird bio up 7 per cent....
August 28, 2017
FT AlphavillePaul Murphy
Paratek, a pharma firm in play?
...And, at a current market cap of circa $560m, Paratek is a more-than-affordable bio-punt for Dublin-based Allergan (market cap $82bn)....
May 4, 2017
News in-depthModerna
Secretive Moderna yet to convince on $5bn valuation
...Big pharma is enthralled....
September 6, 2017
News in-depthPharmaceuticals sector
Digital pill offers chance of new life to old drugs
...Trevor Jones, a veteran of the UK pharma industry, points to data that suggest up to 60 per cent of patients with depression do not take medicines as prescribed....
November 22, 2017
US politics & policy
Pharma recovers composure as price concerns ease
...Public Citizens, the liberal think tank, said leaked drafts of the order suggested “Big Pharma had captured the Trump administration”....
June 21, 2017
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
Juno shares tumble as cancer drug trial halted
...Kite Pharma and Bluebird Bio fell 6 per cent in early trading....
November 23, 2016
US & Canadian companies
Juno cancer drug trial deaths hit biotech shares
...Shares in Kite Pharma, a rival group, fell almost 7 per cent on fears the FDA could take a broader look at the safety of Car-T and potentially suspend other studies, while Bluebird Bio dipped early before...
July 8, 2016
US & Canadian companies
Sanofi makes $9.3bn unsolicited cash offer for Medivation
...In a step towards fulfilling that ambition, it signed two deals in January with biotech companies — Warp Drive Bio and Innate Pharma — worth up to €1.2bn....
April 28, 2016
LombardJonathan Guthrie
Numbers games and existential angst
...GlaxoSmithKline is developing a combination lung disease treatment, known as the “Closed Triple”, with Innoviva, a US pharma group from which the biotech spun off in 2014....
February 4, 2016
US & Canadian companies
How US biotech valuations got stretched
...Of the 144 companies on the Nasdaq biotech index, shares of 137 groups have fallen over the past two days, including drops of more than 15 per cent by Bluebird Bio, Ultragenyx Pharmaceutical, Horizon Pharma...
September 22, 2015
Innovation
Law firms implement tactics to level the playing field
...The second proposal was that Array BioPharma would acquire both products. However, there would need to be a significant European partner to ensure the drugs’ position in the EU market....
October 1, 2015
Pharmaceuticals sector
Gaps in drugs pipelines spark a flurry of takeover activity
...This month, Alexion, a rare-disease drug developer, agreed to acquire smaller rival Synageva Bio-Pharma for $8.4bn, a 139 per cent premium on its market value before the deal was announced....
June 11, 2015
US & Canadian companies
Procter & Gamble puts skin in 3D bioprinting game
...“There’s a lot of interest from both consumer goods companies and big pharma in bioprinting....
May 25, 2015
News in-depthThe Big Read
Biotech: Making sense of the science
...That is propitious for some of the groups that recently completed IPOs, such as Bluebird Bio, a specialist in rare diseases, which has seen its market capitalisation surge by almost 400 per cent to $4bn...
April 13, 2015
UK small companies
Sinclair IS Pharma buys Kelo-cote for £16.7m
...Surrey-based Sinclair, which in April agreed to merge with Aim-quoted IS Pharma, on Thursday agreed to pay £21m for the non-US business of dermatological specialist Advanced Bio-Technologies....
December 8, 2011

Previous pagePage 1 of 2Next page